Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SHBG | P04278 | 1/20 | 0.35 |
| ▸ | DPP4 | P27487 | 2/20 | 0.30 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3546702 | 0.83 | SHBG (0.35) | SHBGDPP4DPP7 | |
| SCHEMBL3542522 | 0.80 | LMNA (0.31) | SHBG | |
| SCHEMBL3541646 | 0.79 | SHBG (0.34) | SHBG | |
| SCHEMBL11789675 | 0.78 | — | — | |
| SCHEMBL14707875 | 0.76 | — | — | |
| SCHEMBL18643470 | 0.76 | — | — | |
| SCHEMBL2937161 | 0.76 | — | — | |
| SCHEMBL11619905 | 0.76 | — | — | |
| SCHEMBL2937162 | 0.76 | — | — | |
| SCHEMBL12519277 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7732627-B2 | High-purity cycloaliphatic diepoxy compound and preparation process thereof | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2010-06-08 | — | — | US | disclosed |
| US-20080045729-A1 | High-Purity Cycloaliphatic Diepoxy Compound and Preparation Process Thereof | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2008-02-21 | — | — | US | disclosed |
| EP-1834949-A1 | HIGH-PURITY ALICYCLIC DIEPOXY COMPOUND AND PROCESS FOR PRODUCING THE SAME | Daicel Chemical Industries, Ltd. (JP) | 2007-09-19 | — | — | EP | disclosed |
| US-20070179256-A1 | High-purity alicyclic epoxy compound, process for production of the same, curable epoxy resin composition, cured product thereof, and application thereof | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2007-08-02 | — | — | US | disclosed |
| EP-1726588-A1 | HIGH-PURITY ALICYCLIC EPOXY COMPOUND, PROCESS FOR PRODUCING THE SAME, CURABLE EPOXY RESIN COMPOSITION, CURED ARTICLE THEREOF, AND USE | Daicel Chemical Industries, Ltd. (JP) | 2006-11-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080045729-A1 | High-Purity Cycloaliphatic Diepoxy Compound and Preparation Process Thereof | DUOX2, SQLE, HPD | SHBG 1758/4885DPP4 4414/4885DPP7 3357/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.